Lixte Biotechnology Holdings, Inc. (LIXT)
NASDAQ: LIXT · Real-Time Price · USD
2.510
+0.070 (2.87%)
At close: Mar 9, 2026, 4:00 PM EDT
2.560
+0.050 (1.99%)
After-hours: Mar 9, 2026, 5:32 PM EDT
LIXT Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 22 | 5 | 5 | 8 | 16 | 39 | |
| Market Cap Growth | 605.41% | -13.63% | -37.62% | -48.20% | -58.30% | -13.83% | |
| Enterprise Value | 19 | 6 | 4 | 5 | 14 | 42 | |
| Last Close Price | 2.51 | 2.03 | 2.35 | 5.09 | 11.90 | 31.70 | |
| PB Ratio | 6.07 | 5.52 | 1.32 | 1.64 | 3.42 | 7.83 | |
| P/TBV Ratio | 9.27 | - | 10.68 | 5.09 | 12.68 | 25.95 | |
| Net Debt / Equity Ratio | -0.59 | -1.26 | -1.05 | -1.04 | -1.01 | -1.01 | |
| Quick Ratio | 5.54 | 3.26 | 13.39 | 13.53 | 15.92 | 23.41 | |
| Current Ratio | 10.42 | 3.60 | 13.73 | 14.05 | 16.81 | 24.15 | |
| Return on Equity (ROE) | -130.06% | -148.73% | -111.07% | -126.81% | -137.28% | -87.69% | |
| Return on Assets (ROA) | -68.32% | -81.88% | -64.47% | -74.05% | -81.39% | -51.68% | |
| Return on Capital Employed (ROCE) | -79.30% | -431.90% | -127.40% | -122.20% | -140.30% | -65.20% | |
| Earnings Yield | -18.90% | -78.55% | -96.24% | -74.50% | -41.13% | -8.32% | |
| Buyback Yield / Dilution | -51.69% | -17.41% | -21.10% | -17.41% | -19.48% | -0.92% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.